Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03012490Not ApplicableCompleted

Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy

Role: collaborator

NCT06756282Recruiting

One Year Pacing Dependency After TAVR

Role: collaborator

NCT04555174Active Not Recruiting

BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry

Role: collaborator

NCT02273648Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Role: lead

NCT02482844Phase 4Unknown

Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm

Role: collaborator

NCT01930903Not ApplicableUnknown

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon

Role: lead

NCT01134380Completed

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Role: lead

NCT01006746Completed

Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation

Role: lead

NCT01108692Not ApplicableCompleted

Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)

Role: lead

NCT00989326Not ApplicableCompleted

Evaluate the Benefits of Pacemaker Follow-Up With Home-Monitoring

Role: lead

All 10 trials loaded